chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product label confusion, Wrong product administered
Clinical narrative: gave a child the monovalent vaccine instead of the Moderna bivalent vaccine; Monovalent vaccine labeled as booster dose being given for the bivalent vaccine; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (gave a child the monovalent vaccine instead of the Moderna bivalent vaccine), PRODUCT LABEL CONFUSION (Monovalent vaccine labeled as booster dose being given for the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (gave a child the monovalent vaccine instead of the Moderna bivalent vaccine), PRODUCT LABEL CONFUSION (Monovalent vaccine labeled as booster dose being given for the bivalent vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (gave a child the monovalent vaccine instead of the Moderna bivalent vaccine), PRODUCT LABEL CONFUSION (Monovalent vaccine labeled as booster dose being given for the bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (gave a child the monovalent vaccine instead of the Moderna bivalent vaccine) and PRODUCT LABEL CONFUSION (Monovalent vaccine labeled as booster dose being given for the bivalent vaccine).    No concomitant medication was provided by the reporter. The pharmacist administered the dose out of the monovalent vial labeled for booster dose with the blue cap and the purple border and the labeling contributed to the mistake as she thought that she was administering the bivalent booster dose. No treatment medication was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 25-Oct-2022: Follow up received included QE number.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Slight sore right arm.; tired; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Slight sore right arm.) and FATIGUE (tired) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 prophylaxis.     Concomitant products included SILDENAFIL and OMEPRAZOLE for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (Slight sore right arm.) and FATIGUE (tired). At the time of the report, PAIN IN EXTREMITY (Slight sore right arm.) and FATIGUE (tired) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2022-663256, MOD-2022-663266 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Micturition urgency, Nausea
Clinical narrative: Patient had to urinate every hour or two during the night; Patient had the shakes during the night with chills; pain in both of kidneys; pain and swelling at site; pain and swelling at site; Nausea; Headache; fatigue; Chills; This spontaneous case was reported by a patient and describes the occurrence of MICTURITION URGENCY (Patient had to urinate every hour or two during the night), TREMOR (Patient had the shakes during the night with chills), RENAL PAIN (pain in both of kidneys), VACCINATION SITE PAIN (pain and swelling at site) and VACCINATION SITE SWELLING (pain and swelling at site) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Oct-2022 at 3:05 PM, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 24-Oct-2022, the patient experienced MICTURITION URGENCY (Patient had to urinate every hour or two during the night), TREMOR (Patient had the shakes during the night with chills), RENAL PAIN (pain in both of kidneys), VACCINATION SITE PAIN (pain and swelling at site), VACCINATION SITE SWELLING (pain and swelling at site), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (fatigue) and CHILLS (Chills). At the time of the report, MICTURITION URGENCY (Patient had to urinate every hour or two during the night), TREMOR (Patient had the shakes during the night with chills), RENAL PAIN (pain in both of kidneys), VACCINATION SITE PAIN (pain and swelling at site), VACCINATION SITE SWELLING (pain and swelling at site), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (fatigue) and CHILLS (Chills) outcome was unknown.            No concomitant medications were reported.  All in all, it was a most serious reaction. This was fifth shot and, previously, patient had a more serious reaction, but different symptoms, only to first shot. The other shots were tolerated with no side effects.  No treatment medications were reported.   This case was linked to MOD-2022-664039 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Renal pain, Tremor, Vaccination site pain, Vaccination site swelling
Clinical narrative: Patient had to urinate every hour or two during the night; Patient had the shakes during the night with chills; pain in both of kidneys; pain and swelling at site; pain and swelling at site; Nausea; Headache; fatigue; Chills; This spontaneous case was reported by a patient and describes the occurrence of MICTURITION URGENCY (Patient had to urinate every hour or two during the night), TREMOR (Patient had the shakes during the night with chills), RENAL PAIN (pain in both of kidneys), VACCINATION SITE PAIN (pain and swelling at site) and VACCINATION SITE SWELLING (pain and swelling at site) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Oct-2022 at 3:05 PM, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 24-Oct-2022, the patient experienced MICTURITION URGENCY (Patient had to urinate every hour or two during the night), TREMOR (Patient had the shakes during the night with chills), RENAL PAIN (pain in both of kidneys), VACCINATION SITE PAIN (pain and swelling at site), VACCINATION SITE SWELLING (pain and swelling at site), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (fatigue) and CHILLS (Chills). At the time of the report, MICTURITION URGENCY (Patient had to urinate every hour or two during the night), TREMOR (Patient had the shakes during the night with chills), RENAL PAIN (pain in both of kidneys), VACCINATION SITE PAIN (pain and swelling at site), VACCINATION SITE SWELLING (pain and swelling at site), NAUSEA (Nausea), HEADACHE (Headache), FATIGUE (fatigue) and CHILLS (Chills) outcome was unknown.            No concomitant medications were reported.  All in all, it was a most serious reaction. This was fifth shot and, previously, patient had a more serious reaction, but different symptoms, only to first shot. The other shots were tolerated with no side effects.  No treatment medications were reported.   This case was linked to MOD-2022-664039 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: the vial was initially stored in the refrigerator on 23Sep2022 and administration of vaccine on 24Oct2022; No adverse event; Patient received a dose of Moderna Covid-19, Bivalent 1 day past the beyond use date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a dose of Moderna Covid-19, Bivalent 1 day past the beyond use date), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 23Sep2022 and administration of vaccine on 24Oct2022) and NO ADVERSE EVENT (No adverse event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 24-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a dose of Moderna Covid-19, Bivalent 1 day past the beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 23Sep2022 and administration of vaccine on 24Oct2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a dose of Moderna Covid-19, Bivalent 1 day past the beyond use date), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 23Sep2022 and administration of vaccine on 24Oct2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received a dose of Moderna Covid-19, Bivalent 1 day past the beyond use date) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 23Sep2022 and administration of vaccine on 24Oct2022).    No concomitant medications were reported.  Individual vials or unbroken cartons was 1 dose. Vial size was 2.5 mL The vial was initially stored in the refrigerator was 23-Sep-2022 The vial did not undergo any temperature excursions.  No treatment medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 013A21A and 010M20A) for COVID-19 prophylaxis. No Medical History information was reported. On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. No concomitant drug information was provided. It was reported that patient had headache with all the previous Moderna doses. No treatment drug information was provided. This case was linked to MOD-2022-662834 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: No adverse event; The patient's first dose of Moderna was on 03-JUL-2022 and second dose on 26-JUL-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient's first dose of Moderna was on 03-JUL-2022 and second dose on 26-JUL-2022) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 03-Jul-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jul-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient's first dose of Moderna was on 03-JUL-2022 and second dose on 26-JUL-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient's first dose of Moderna was on 03-JUL-2022 and second dose on 26-JUL-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (The patient's first dose of Moderna was on 03-JUL-2022 and second dose on 26-JUL-2022).    No concomitant medication information was provided.  The Moderna vaccine for children under 4 were given too early and they are looking for some guidance. It was their second dose of the primary series that was given too early.  This case contains information for the Child 2 described by the reporter.  No treatment medication was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-663893 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-663893:(child 1) (same reporter)
Sex: U
Vaccine: COVID19
Symptoms: Immunisation reaction
Clinical narrative: I had a more serious reaction, but different symptoms, only to my first shot.; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (I had a more serious reaction, but different symptoms, only to my first shot.) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (I had a more serious reaction, but different symptoms, only to my first shot.). At the time of the report, IMMUNISATION REACTION (I had a more serious reaction, but different symptoms, only to my first shot.) outcome was unknown.        mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.       Concomitant medication list was not provided. The patient reported that patient had a more serious reaction, but different symptoms, only to the first shot. The other shots were tolerated with no side effects. Treatment information was not provided.   This case was linked to MOD-2022-663877 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: No adverse event; Received 0.25ml Bivalent booster instead of 0.5 ml; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Received 0.25ml Bivalent booster instead of 0.5 ml) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 vaccination. No Medical History information was reported. On 24-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 24-Oct-2022, the patient experienced UNDERDOSE (Received 0.25ml Bivalent booster instead of 0.5 ml). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Received 0.25ml Bivalent booster instead of 0.5 ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Received 0.25ml Bivalent booster instead of 0.5 ml).  No concomitant medications was provided. No treatment medications was provided.   This case was linked to MOD-2022-664521 (Patient Link).
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive for covid; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (Tested positive for covid) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In October 2022, the patient experienced COVID-19 (Tested positive for covid). At the time of the report, COVID-19 (Tested positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2022, SARS-CoV-2 test: Positive.         No concomitant medication was reported.    Reporter stated his father(patient) also received his Moderna vaccines and tested positive for Covid around the same timeframe. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-664569 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-664569:Reporter's case
Age: 40.0
Sex: F
Vaccine: TD
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: medication error due to the administration of an expired product,with no reported adverse event; Initial information  received on 21-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 40 years old female patient who experienced medication error due to the administration of an expired product DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] ,with no reported adverse event.    The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 21-Oct-2022, the patient received a  dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (lot U6852AA and expiry 17-Oct-22) (expired product administered, latency same day) (dose, formulation and strength: unknown) via intramuscular route in the left deltoid for immunization.   Action taken with DIPHTHERIA AND TETANUS TOXOIDS (TENIVAC) was not applicable.  At time of reporting, the outcome was Unknown for the event medication error due to the administration of an expired product,with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 87.0
Sex: M
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Error: Wrong Vaccine/Product Administered-
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 9.0
Sex: F
Vaccine: FLU4
Symptoms: Confusional state, Dizziness, Fear, Hypoacusis, Nervousness
Clinical narrative: Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Additional Details: After receiving vaccine, patient was leaving with father and fainted. When patient awoke she was unable to hear her father speaking to her and appeared confused. Patient appeared frightened/nervous while receiving the vaccine and tried pulling away as I was giving the vaccine. The needle was in the arm and I was able to administer the vaccine in the correct place. Patient did not eat since 12pm. she was given orange juice when she awoke. Ambulance was called and patient left in ambulance
Age: 9.0
Sex: F
Vaccine: FLU4
Symptoms: Syncope
Clinical narrative: Systemic: Confusion-Severe, Systemic: Dizziness / Lightheadness-Severe, Additional Details: After receiving vaccine, patient was leaving with father and fainted. When patient awoke she was unable to hear her father speaking to her and appeared confused. Patient appeared frightened/nervous while receiving the vaccine and tried pulling away as I was giving the vaccine. The needle was in the arm and I was able to administer the vaccine in the correct place. Patient did not eat since 12pm. she was given orange juice when she awoke. Ambulance was called and patient left in ambulance
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Confusional state, Dizziness, Fatigue, Flushing
Clinical narrative: Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: Patient was shaking upon initial injection of the Pfizer bivalent (but vaccine was not pushed through yet). After the vaccine was given, patient said she felt light-headed and felt like she was going to faint. Patient later was disoriented and and passing in and out. Patient soiled herself as well. Firefighters reported that she most likely had low blood sugar levels. She ultimately came back and a checkup at the hospital. Her other vaccine was not given that day.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hyperhidrosis, Incontinence, Lethargy, Syncope, Tremor
Clinical narrative: Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: Patient was shaking upon initial injection of the Pfizer bivalent (but vaccine was not pushed through yet). After the vaccine was given, patient said she felt light-headed and felt like she was going to faint. Patient later was disoriented and and passing in and out. Patient soiled herself as well. Firefighters reported that she most likely had low blood sugar levels. She ultimately came back and a checkup at the hospital. Her other vaccine was not given that day.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unresponsive to stimuli
Clinical narrative: Systemic: Confusion-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Medium, Systemic: Weakness-Medium, Additional Details: Patient was shaking upon initial injection of the Pfizer bivalent (but vaccine was not pushed through yet). After the vaccine was given, patient said she felt light-headed and felt like she was going to faint. Patient later was disoriented and and passing in and out. Patient soiled herself as well. Firefighters reported that she most likely had low blood sugar levels. She ultimately came back and a checkup at the hospital. Her other vaccine was not given that day.
Age: 93.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Dose in Series Given Too Early-
Age: 11.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 25.0
Sex: M
Vaccine: COVID19-2
Symptoms: Fall, Pallor, Syncope
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Additional Details: PT HAD BOTH VACCINES THEN COMMENTED THAT EASY THEN 5 SECONDS LATER FAINTED.   HE THEN WOKE UP, 5 SECS LATER WITH NO IDEA OF HOW HE ENDED UP ON FLOOR.  HE APPEARED PALE AND STAYED FOR 30 MINS AND SAID HE FELT FINE AND LEFT.
Age: 32.0
Sex: F
Vaccine: COVID19-2
Symptoms: Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Severe
Age: 77.0
Sex: F
Vaccine: PNC20
Symptoms: Chills, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Fever-Medium
Age: 77.0
Sex: F
Vaccine: PNC20
Symptoms: Pain, Pyrexia
Clinical narrative: Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Medium, Systemic: Fever-Medium
Age: 25.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: Cellulitis, Injection site erythema, Injection site mass, Injection site oedema, Injection site pain
Clinical narrative: developed ++left arm soreness with pain 6/10 constant especially with movement non radiating night of 10/22/22 to left deltoid and noticed "golf bal"l size lump mid bicep brachi. + redness no streaking, + warmth, with edema. Urgent care 10/24/22 diagnosed with celluitis and treated with keflex 500 mg QID  x 7 days Evaluated employee health 10/20/22 improvement in lump to upper left deltoid subsideing no further redness, no streaking, no warmth, no edema, slight tenderness if pushes on it, + itching, pain 0/10. full ROM. denies any SOB, CP, fatigue, chills, fever, muscle aches, dizziness, working full duties without difficulty as unit clerk. keflex completed 10/29/22.
Age: 67.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pruritus, Injection site warmth, Pain, Pain in extremity
Clinical narrative: developed ++left arm soreness with pain 6/10 constant especially with movement non radiating night of 10/22/22 to left deltoid and noticed "golf bal"l size lump mid bicep brachi. + redness no streaking, + warmth, with edema. Urgent care 10/24/22 diagnosed with celluitis and treated with keflex 500 mg QID  x 7 days Evaluated employee health 10/20/22 improvement in lump to upper left deltoid subsideing no further redness, no streaking, no warmth, no edema, slight tenderness if pushes on it, + itching, pain 0/10. full ROM. denies any SOB, CP, fatigue, chills, fever, muscle aches, dizziness, working full duties without difficulty as unit clerk. keflex completed 10/29/22.
Age: 33.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chills, Headache, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Headache, body chills and aches, swollen lymph nodes, fever up to 104.5 at 2 AM, fever down to 100.6 by 6:30 AM  Advil taken at 7 am
Age: 77.0
Sex: F
Vaccine: FLUA4
Symptoms: Dizziness, Injection site pruritus, Pruritus
Clinical narrative: Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Dizziness / Lightheadness-Mild, Additional Details: Within 15 minutes of giving the vaccine, the patient developed itching around the site of injection and gave water and 25 mg of benadryl. Patient also had mild dizziness and responded well to water and crackers. Observed the patient for additonal 30 minutes. Spoke with the patietn over the phone one hour later, she reported that her symptoms are improved. Of note the patient got fluad quad in the previous year 2021 with no issues reported.
Age: 21.0
Sex: F
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Error: Wrong Vaccine/Product Administered-
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abdominal pain, Asthenia, Chills, Dizziness, Fatigue
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Severe, Systemic: Shakiness-Severe, Systemic: Tachycardia-Medium, Systemic: Vomiting-Severe, Systemic: Weakness-Severe, Additional Details: extreme vertigo
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Flushing, Hyperhidrosis, Injection site erythema, Lethargy, Nausea
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Severe, Systemic: Shakiness-Severe, Systemic: Tachycardia-Medium, Systemic: Vomiting-Severe, Systemic: Weakness-Severe, Additional Details: extreme vertigo
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pain, Pyrexia, Tachycardia, Tremor, Vertigo
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Severe, Systemic: Shakiness-Severe, Systemic: Tachycardia-Medium, Systemic: Vomiting-Severe, Systemic: Weakness-Severe, Additional Details: extreme vertigo
Age: 66.0
Sex: M
Vaccine: COVID19-2
Symptoms: Vomiting
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Severe, Systemic: Shakiness-Severe, Systemic: Tachycardia-Medium, Systemic: Vomiting-Severe, Systemic: Weakness-Severe, Additional Details: extreme vertigo
Age: 63.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site bruising, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Age: 22.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Fall, Seizure, Syncope, Tremor
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Seizure-Mild, Systemic: Shakiness-Mild, Additional Details: Patient came in to receive both the seasonal flu vaccine and the pfizer bivalent booster. seconds later she feld lightheaded and then she slid down the chair and had a seizure. parametics were called and she was evaluated. they recommended she go with them but she refused.
Age: 22.0
Sex: F
Vaccine: COVID19-2
Symptoms: Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Seizure-Mild, Systemic: Shakiness-Mild, Additional Details: Patient came in to receive both the seasonal flu vaccine and the pfizer bivalent booster. seconds later she feld lightheaded and then she slid down the chair and had a seizure. parametics were called and she was evaluated. they recommended she go with them but she refused.
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dermatitis allergic, Injection site pruritus, Pruritus, Rash, Rash pruritic
Clinical narrative: Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Systemic: rash under breasts-Mild, Additional Details: Patient received vacccine and a day later had an itchy rash under her breasts
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injury associated with device
Clinical narrative: Error: Patient Accidentally Stuck by Needle-
Age: 89.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 13.0
Sex: F
Vaccine: COVID19-2
Symptoms: Injection site erythema, Lymphadenopathy
Clinical narrative: Site: Redness at Injection Site-Mild, Systemic: Lymph Node Swelling-Medium, Additional Details: Patient's grandmother claims pharmacist gave flu and covid shots less than an inch apart which caused lymph node swelling. Believes shots are now ineffective.
Age: 83.0
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Dehydration, Fall, Pyrexia
Clinical narrative: fever dehydration weakness fell out of bed
Age: 71.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Injection site pain, Tachycardia
Clinical narrative: Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Tachycardia-Medium
Age: 15.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Hyperhidrosis, Muscular weakness
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Weakness-Mild, Additional Details: patient recieved vaccination at 5:25 PM . at 5:30 pm she felt weak at the knees, and was feeling faint, and was sweating, therefore EMS was called and they checked her vitals in the ambulance. Patient was awake and aware and felt better by the time the ambulance arrived.
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chills, Disorientation, Dizziness, Loss of consciousness, Pyrexia
Clinical narrative: Bad chills, light fever, light headed then after chills went away I passed out and became disoriented.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Lip swelling, Paraesthesia
Clinical narrative: Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Additional Details: swelling of the lips, and numbness/tingling of the left side of the face
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation (ex. Prevnar 13 v. Prevnar 23)-
Age: 12.0
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: Patient needed a different vaccine for school qualification, needed conjugate vaccine instead. Patient qualified for both since over age of 10 based off guidelines, however school requirement only conjugate will qualify.
Age: 57.0
Sex: F
Vaccine: COVID19-2
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes under left armpit
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal distension, Abdominal pain upper, Chest discomfort, Chest pain, Cholecystitis
Clinical narrative: Started experiencing gastrointestinal problems. 1st event Culminated July 10 i2021 with intense chest pressure/pain and severe bloating with nausea, vomiting and stomach pains. Severe painful symptoms began around 9 or 10 PM and lasted about 6 hrs. Entire event lasted a couple of days. Have experienced the same symptoms three more times. Latest attack occurred 24 Oct. cat scan revealed infected gall bladder. Currently taking antibiotics  and more tests to be performed.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Cholecystitis infective, Computerised tomogram abnormal, Diverticulitis, Gastrointestinal disorder, Laboratory test
Clinical narrative: Started experiencing gastrointestinal problems. 1st event Culminated July 10 i2021 with intense chest pressure/pain and severe bloating with nausea, vomiting and stomach pains. Severe painful symptoms began around 9 or 10 PM and lasted about 6 hrs. Entire event lasted a couple of days. Have experienced the same symptoms three more times. Latest attack occurred 24 Oct. cat scan revealed infected gall bladder. Currently taking antibiotics  and more tests to be performed.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Started experiencing gastrointestinal problems. 1st event Culminated July 10 i2021 with intense chest pressure/pain and severe bloating with nausea, vomiting and stomach pains. Severe painful symptoms began around 9 or 10 PM and lasted about 6 hrs. Entire event lasted a couple of days. Have experienced the same symptoms three more times. Latest attack occurred 24 Oct. cat scan revealed infected gall bladder. Currently taking antibiotics  and more tests to be performed.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspepsia, Vomiting
Clinical narrative: Indigestion for days in a row.  Throws up undigested food (from lunch time/dinner time)  in bed while asleep.  None of the food had been broken down.
Age: 77.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: PT REPORTED REDNESS, SWELLING AND PAIN AT THE INJECTION SITE
Age: 20.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given Bivalent dose instead of second dose of primary series.  No treatment or side effects.
Age: 12.0
Sex: M
Vaccine: COVID19-2
Symptoms: Wrong product administered
Clinical narrative: Patient received Pfizer bivalent age 5-11 and patient is 12 years old.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: I had a breakthrough case of Covid, I was prescribed PAXLOVID.
Age: 5.0
Sex: M
Vaccine: TDAP
Symptoms: Incorrect dose administered, Product administered to patient of inappropriate age
Clinical narrative: given adolescent dose.
Age: 87.0
Sex: F
Vaccine: FLUR4
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient attended a clinic at the Health Department on 10/26/2022 accompanied by son in law, who requested that she receive a flu shot.  Flublok was administered.  Daughter called HD on 10/27/22 to advise that patient had received a flu shot at her assisted living facility the previous week and request had been made in error.  Staff with the Assisted Living Facility on 10/27/22 and confirmed that patient had received Fluzone High dose on 10/21/2022.  To date, there have been no reports of an adverse reaction.
Age: 54.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Dyspnoea, Palpitations
Clinical narrative: At 3:36 pm- while sitting in the observation area client was approach by observation nurse when client complained of shortness of breath, and stated heart racing.?  Intervention included extremities elevated, cold compresses, and water offered, vital signs initiated, and emotional support provided; client remained  alert ,calm and responsive. No changed in mental status noted. Observation extended to 30 minutes. Last set of vital signs within normal limits. client was observed walking and talking on steady gait before leaving site, client was made aware to self-monitor for non-resolving, recurring or worsening symptoms. Client left on stable condition on steady gait at 4:08 pm.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Head discomfort, Headache, Nasal congestion, SARS-CoV-2 test positive
Clinical narrative: I had a severe sinus infection with nasal drip. I also had facial fullness with a headache and stuffiness. By the end of that week, I tested myself to see if I had COVID-19. I believe I contracted the virus around the 10th of September. I spoke to my doctor who called in a Z-PAK and told me to take vitamin C and zinc. Within a few days, I got better. At this point I have completely recovered from all my symptoms.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis, Upper-airway cough syndrome
Clinical narrative: I had a severe sinus infection with nasal drip. I also had facial fullness with a headache and stuffiness. By the end of that week, I tested myself to see if I had COVID-19. I believe I contracted the virus around the 10th of September. I spoke to my doctor who called in a Z-PAK and told me to take vitamin C and zinc. Within a few days, I got better. At this point I have completely recovered from all my symptoms.
Age: 54.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Headache, Pain
Clinical narrative: Fatigue, Headache, Body Aches
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Computerised tomogram, Dyspnoea exertional, Fibrin D dimer, Impaired work ability
Clinical narrative: I started to get winded whenever I walked a short distance around the end of January and beginning of February 2022. I called my physician and then I went to the Emergency Room. I took several tests. I was hospitalized for 2 days. A blood clot behind my right knee was discovered. I was also diagnosed with Bilateral pulmonary emboli. I have not been at work since February 2022. I was put on blood thinners.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary embolism, Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: I started to get winded whenever I walked a short distance around the end of January and beginning of February 2022. I called my physician and then I went to the Emergency Room. I took several tests. I was hospitalized for 2 days. A blood clot behind my right knee was discovered. I was also diagnosed with Bilateral pulmonary emboli. I have not been at work since February 2022. I was put on blood thinners.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Headache, Nasal congestion, Oropharyngeal pain
Clinical narrative: On Sunday, 10/23/2022, it started with a slight headache, but that went pretty quickly. The following Tuesday, in the early morning, I woke up with the worst sore throat I've ever had. I went to my volunteer job that day and only coughed once all day. Wednesday though, I woke up with a stuffy nose. I went to get tested for COVID-19, as I do once a month. After I tested positive, I met with the doctor. He suggested that I take cough medicine and TYLENOL. My primary care doctor prescribed PAXLOVID which I will begin taking this morning. I still have a runny nose and nasal congestion but no fever or chills.
Age: 78.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: On Sunday, 10/23/2022, it started with a slight headache, but that went pretty quickly. The following Tuesday, in the early morning, I woke up with the worst sore throat I've ever had. I went to my volunteer job that day and only coughed once all day. Wednesday though, I woke up with a stuffy nose. I went to get tested for COVID-19, as I do once a month. After I tested positive, I met with the doctor. He suggested that I take cough medicine and TYLENOL. My primary care doctor prescribed PAXLOVID which I will begin taking this morning. I still have a runny nose and nasal congestion but no fever or chills.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive, Skin discolouration
Clinical narrative: I was in a residential facility visiting my mother and was exposed to an individual that tested positive for COVID-19, I tested positive for COVID-19 myself two days later. I was prescribed PAXLOVID by my doctor and recovered from COVID-19 but I had a rebound case two days later. My right thumb turned purple during my rebound case and time and has stayed purple.
Age: 10.0
Sex: F
Vaccine: COVID19-2, FLU4, HEP, IPV, MMR, TDAP
Symptoms: Immunisation reaction, Wrong product administered
Clinical narrative: Administered Age appropriate Bivalent instead of Monovalent for correct age to child who didn't receive Monovalent Series.  Contacted Family on 10/27/22. Father reports normal side effects and returned to school today.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Blood test, Hyperhidrosis, Lymphadenopathy, Pain
Clinical narrative: Patient stated that after recieving the COVID vaccine in April 2021 that she began to notice her lymph nodes on her right side (arm up to neck) began to swell. She had to seek medical care in July of 2021 due to the swelling, pain, welts, heart palpitations, and excessive sweating that occured. She went to the Emergency Room at Hospital and they completed ultrasounds and blood work. Ultimately she was not given an diagnosis for her symptoms (she stated that the team spoke about it being vaccine related). She was prescribed Meloxicam for 14 days. Since then her lymph node swelling and pain has resolved. Heart palpitations have ceased. She still has excessive sweating and has suffered from increased acne and red blotchy areas on her face.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Rash, Rash erythematous, Rash macular, Swelling
Clinical narrative: Patient stated that after recieving the COVID vaccine in April 2021 that she began to notice her lymph nodes on her right side (arm up to neck) began to swell. She had to seek medical care in July of 2021 due to the swelling, pain, welts, heart palpitations, and excessive sweating that occured. She went to the Emergency Room at Hospital and they completed ultrasounds and blood work. Ultimately she was not given an diagnosis for her symptoms (she stated that the team spoke about it being vaccine related). She was prescribed Meloxicam for 14 days. Since then her lymph node swelling and pain has resolved. Heart palpitations have ceased. She still has excessive sweating and has suffered from increased acne and red blotchy areas on her face.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan, Urticaria
Clinical narrative: Patient stated that after recieving the COVID vaccine in April 2021 that she began to notice her lymph nodes on her right side (arm up to neck) began to swell. She had to seek medical care in July of 2021 due to the swelling, pain, welts, heart palpitations, and excessive sweating that occured. She went to the Emergency Room at Hospital and they completed ultrasounds and blood work. Ultimately she was not given an diagnosis for her symptoms (she stated that the team spoke about it being vaccine related). She was prescribed Meloxicam for 14 days. Since then her lymph node swelling and pain has resolved. Heart palpitations have ceased. She still has excessive sweating and has suffered from increased acne and red blotchy areas on her face.
Age: 6.0
Sex: F
Vaccine: FLU4
Symptoms: Incorrect dose administered
Clinical narrative: (Agency Flu Nurse) administered adult Pfizer Bivalent COVID Booster dose 0.3 ml to member.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Computerised tomogram head normal, Hypoaesthesia
Clinical narrative: I called EMS due to sudden numbness in my right-arm and on my right-side above the waist. I was concerned about the possibility of a stroke, but EMS ruled-out that as symptoms were not consistent with a stroke. I have had symptoms up until 10-25-2022. The duration and frequency of symptoms seem to be decreasing since the vaccination. They were the most severe in both duration and frequency for the first 7-10 days after the vaccination.
Age: 4.0
Sex: M
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: COVID-19 Pfizer pediatric Bivalent vaccine for the age group 5-11 was administered to a child age 4.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Ovarian cancer
Clinical narrative: Ovarian cancer
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: COVID Pediatric Bivalent vaccine for age group 5-11 was administered to a 2 year old.